NYSE: VTEX · Vtex - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q4 '25 | Q4 '24 | Q4 '23 | Q4 '22 | Q4 '21 | Q4 '20 | Q4 '19 | Q4 '18 |
|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - | - | - |
| SG&A | - | - | - | - | - | - | - | - |
| Total Operating Expenses | - | - | - | - | - | - | - | - |
| D&A | - | - | - | - | - | - | - | - |
| Operating Income | - | - | - | - | - | - | - | - |
| Interest Expense | - | - | - | - | - | - | - | - |
| Income Tax | - | - | - | - | - | - | - | - |
| Net Income | - | - | - | - | - | - | - | - |
| EPS - Basic | - | - | - | - | - | - | - | - |
| EPS - Diluted | - | - | - | - | - | - | - | - |
Balance Sheet
| Line item | Q4 '25 | Q4 '24 | Q4 '23 | Q4 '22 | Q4 '21 | Q4 '20 | Q4 '19 | Q4 '18 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $15.74M | $18.67M | $28.04M | $24.39M | $121.01M | $58.56M | $29.76M | $5.51M |
| Accounts Receivable | $61.60M | $52.52M | $44.12M | $36.84M | $34.68M | $24.49M | - | - |
| Inventory | - | - | - | - | - | - | - | - |
| Accounts Payable | - | - | - | - | - | - | - | - |
| Current Assets | $267.50M | $284.59M | $266.25M | $287.16M | $349.52M | $108.73M | - | - |
| Total Assets | $346.63M | $362.11M | $341.14M | $357.67M | $414.97M | $140.01M | - | - |
| Current Liabilities | $87.96M | $80.02M | $77.24M | $62.02M | $58.89M | $47.06M | - | - |
| Long-term Debt | - | - | - | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - | - | - | - |
| Stockholders' Equity | $233.50M | $254.11M | $238.72M | $272.68M | $327.19M | $75.75M | $47.09M | $10.30M |
| Retained Earnings | ($89.80M) | ($109.81M) | ($130.06M) | ($116.37M) | ($63.95M) | ($3.44M) | - | - |
Cash Flow
| Line item | Q4 '25 | Q4 '24 | Q4 '23 | Q4 '22 | Q4 '21 | Q4 '20 | Q4 '19 | Q4 '18 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - | - | - |
| Investing Cash Flow | - | - | - | - | - | - | - | - |
| Financing Cash Flow | - | - | - | - | - | - | - | - |
| CapEx | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - |
Ratios
| Metric | Q4 '25 | Q4 '24 | Q4 '23 | Q4 '22 | Q4 '21 | Q4 '20 | Q4 '19 | Q4 '18 |
|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||
| Gross margin | - | - | - | - | - | - | - | - |
| Operating margin | - | - | - | - | - | - | - | - |
| EBITDA margin | - | - | - | - | - | - | - | - |
| Net margin | - | - | - | - | - | - | - | - |
| Free cash flow margin | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - |
| SG&A / Revenue | - | - | - | - | - | - | - | - |
| Effective tax rate | - | - | - | - | - | - | - | - |
| Return on assets | - | - | - | - | - | - | - | - |
| Return on equity | - | - | - | - | - | - | - | - |
| Return on invested capital | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||
| Current ratio | 3.04 | 3.56 | 3.45 | 4.63 | 5.94 | 2.31 | - | - |
| Quick ratio | 3.04 | 3.56 | 3.45 | 4.63 | 5.94 | 2.31 | - | - |
| Cash ratio | 0.18 | 0.23 | 0.36 | 0.39 | 2.05 | 1.24 | - | - |
| Leverage | ||||||||
| Debt / Equity | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | - | - | - | - |
| Equity multiplier | 1.48 | 1.42 | 1.43 | 1.31 | 1.27 | 1.85 | - | - |
| Liabilities / Assets | - | - | - | - | - | - | - | - |
| Efficiency | ||||||||
| Asset turnover | - | - | - | - | - | - | - | - |
| Inventory turnover | - | - | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - |
| Valuation | ||||||||
| P / E | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - |
| Growth | ||||||||
| Revenue growth (YoY) | - | - | - | - | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | - | - | - | - | - | - | - | - |
| Net income growth (YoY) | - | - | - | - | - | - | - | - |
| EPS growth (YoY) | - | - | - | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -8.1% | 6.4% | -12.5% | -16.7% | 331.9% | 60.9% | 357.2% | - |
Peer comparison
Same SIC group: Services-Prepackaged Software
Comparing VTEX against the 5 most active filers in the same SIC group.